Understanding the costs of drug-related actions is an important aspect of drug policy. Some of the funds allocated by governments to expenditure on tasks related to drugs are identified as such in the budget (‘labelled’). Often, however, most drug-related expenditure is not identified (‘unlabelled’) and must be estimated using modelling approaches.
The National Programme for the Control and Prevention of Use of Drugs, Tobacco and Alcohol 2018-28 was adopted in 2018. The previous programme, the National Programme on Drug Control and Prevention of Drug Addiction 2010-16, was implemented with the support of action plans that specified, among other things, public expenditure planned.
In 2017, the labelled expenditure announced in the Action Plan on Drugs, Tobacco and Alcohol was EUR 7.8 million (0.02 % of gross national product (GDP)). More than half of this expenditure was intended for supply reduction (61.7 % of the total); 26.8 % was budgeted for demand reduction and 11.1 % for policy coordination.